ALK targeting vaccine (Vedantra Pharmaceuticals)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug NameALK targeting vaccine (Vedantra Pharmaceuticals)
Drug Alias Nameanaplastic lymphoma kinase targeting vaccine (Vedantra Pharmaceuticals)
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionAnaplastic lymphoma kinase inhibitors
TargetsAnaplastic lymphoma kinase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesElicio Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesElicio Therapeutics
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A